Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Railey Molinario Relationship Intelligence Expert Unveils RI, a Scalable Framework for Building Stronger Human Connections
-
Iovance Announces Five-year Results of Amtagvi® (lifileucel) in Patients with Advanced Melanoma at ASCO Annual Meeting
-
ELV INVESTOR DEADLINE: Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FAST TRACK GROUP Announces Pricing of $15 Million Initial Public Offering
-
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
-
Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting
-
RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting
-
Merus’ Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC
-
Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)
-
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
-
Bitwise Announces Monthly Distributions for IMST, ICOI, and IMRA
-
PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annua
-
Prayers for Peace
-
Universal Digital Inc. Files Preliminary Prospectus for 2X Crypto Equity ETFs
-
RCF Opportunities Fund II L.P. Files Early Warning Report Regarding Common Shares of Defense Metals Corp.
-
Inomin Announces Non-Brokered Private Placement
-
Abcourt Announces its Results for the Third Quarter Ended March 31, 2025
-
Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress
-
ARBA Retail Systems: Powering the Future of Retail with Artificial Intelligence
-
IMUNON Announces Withdrawal of Form S-1 Registration Statement
-
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel
-
Daktronics to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28th
-
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
-
Generic Gold Announces Resignation of Director
-
KBRA Assigns Preliminary Ratings to BX 2025-LUNR
-
Gaza on the Brink: Action Against Hunger Races To Prevent Child Malnutrition
-
ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025
-
AOC Remains the World's #1 Gaming Monitor Brand for the Sixth Year Running
-
Halliburton Announces Dividend
-
M-tron Industries, Inc. to Host Investor Presentation followed by Annual Meeting of Stockholders on June 10, 2025
-
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
-
Haivision to Announce Second Quarter Fiscal 2025 Financial Results on June 11, 2025
-
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
-
Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting
-
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
-
ROHM Develops Compact Surface-Mount Near-Infrared LEDs Featuring Industry-Leading Radiant Intensity
-
Erie’s Public Schools and Zurn Elkay Water Solutions Announce Donation for Cleaner, Healthier, Safer Drinking Water
-
Lynch Carpenter Investigates Claims in Marlboro-Chesterfield Pathology Data Breach
-
Servotronics Announces Important Development with the Annual Meeting of Shareholders
-
Lynch Carpenter Investigates Claims in Kettering Health Data Breach
-
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting
-
Banco Comercial Português, S.A. informs about resolutions of the Annual General Meeting
-
Prospector Announces Final Closing of its Non-Brokered Private Placement to Fund Drilling on the ML Project, Yukon
-
Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
-
Boehringer Ingelheim to present early clinical evidence of innate immune modulation and anti-tumor activity via SIRPα blockade in two ongoing trials at ASCO 2025
-
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
-
Lilly announces details of presentations at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Actuate Therapeutics Announces Details for 2025 ASCO Annual Meeting Presentation on Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
-
Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
-
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients
